DAIC

MARCH 27, 2025

In 2024, the FDA approved Flyrcado for patients with known or suspected coronary artery disease (CAD), delivering higher diagnostic efficacy compared to single-photon emission computed tomography (SPECT) i myocardial perfusion imaging (MPI), the predominant procedure used in nuclear cardiology today. 2023 Oct, 82 (16) 15981610.

Coronary Artery Disease 52

Coronary Artery Disease CMS Innovation Ischemia 52

DAIC

MARCH 28, 2025

v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. CCTA offers a non-invasive, cost-effective, and highly sensitive method for diagnosing coronary artery disease (CAD), making it a valuable tool for clinicians.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

DAIC

JANUARY 23, 2024

The new code, designated by The American Medical Association ( AMA ), supports FFRCT as the standard of care in assessing patients with suspected coronary artery disease ( CAD ). In the hospital setting, CMS increased payment for the FFRCT service by ~7% for 2024.

Reimbursement 105

Reimbursement Coronary Artery Disease CMS Technology 105

DAIC

OCTOBER 16, 2024

15 , 2024 — Four of the seven Medicare Administrative Contractors (MACs) have released final local coverage determinations (LCD) for AI-Coronary Plaque Analysis (AI-CPA). tim.hodson Wed, 10/16/2024 - 12:36 Oct. The four contractors for the U.S. The LCDs have a future effective date of Nov.

CMS 52

CMS Medicare Plaque Chest Pain 52

DAIC

MARCH 7, 2024

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and discussed at the Radiological Society of North America109th Scientific Assembly and Annual Meeting (RSNA23). As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38

Technology 111

Technology Document Cardiovascular Imaging Cancer 111